Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Intraday Session

Author: Benzinga Insights | February 21, 2024 01:31pm

Gainers

  • Emergent BioSolutions (NYSE:EBS) stock increased by 77.0% to $2.69 during Wednesday's regular session. The market value of their outstanding shares is at $139.5 million.
  • Ventyx Biosciences (NASDAQ:VTYX) shares moved upwards by 72.07% to $5.14. The market value of their outstanding shares is at $303.8 million.
  • Motus GI Hldgs (NASDAQ:MOTS) stock increased by 54.07% to $1.0. The company's market cap stands at $1.5 million.
  • Janux Therapeutics (NASDAQ:JANX) shares increased by 35.54% to $13.5. The market value of their outstanding shares is at $623.2 million.
  • RAPT Therapeutics (NASDAQ:RAPT) stock rose 26.05% to $8.66. The company's market cap stands at $297.8 million.
  • Iovance Biotherapeutics (NASDAQ:IOVA) stock rose 24.1% to $14.93. The company's market cap stands at $3.8 billion.

Losers

  • BioSig Technologies (NASDAQ:BSGM) shares fell 29.2% to $0.37 during Wednesday's regular session. The market value of their outstanding shares is at $3.4 million.
  • PHAXIAM Therapeutics (NASDAQ:PHXM) shares decreased by 26.33% to $2.79. The company's market cap stands at $16.9 million.
  • Community Health Sys (NYSE:CYH) stock decreased by 25.87% to $3.0. The company's market cap stands at $409.7 million. The company's, Q4 earnings came out yesterday.
  • Teladoc Health (NYSE:TDOC) shares fell 25.21% to $15.32. The company's market cap stands at $2.5 billion. The company's, Q4 earnings came out yesterday.
  • Kazia Therapeutics (NASDAQ:KZIA) shares declined by 24.39% to $0.3. The market value of their outstanding shares is at $7.9 million.
  • NKGen Biotech (NASDAQ:NKGN) stock decreased by 20.64% to $1.0. The company's market cap stands at $21.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BSGM CYH EBS IOVA JANX KZIA MOTS NKGN PHXM RAPT TDOC VTYX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist